Sanofi EBITDA 2010-2025 | SNY

Sanofi EBITDA for the quarter ending March 31, 2025 was $2.443B, a 59.36% increase year-over-year.

  • Sanofi 2024 EBITDA was 12.1B, a 18.13% decline from 2023.
  • Sanofi 2023 EBITDA was 14.78B, a 3.18% increase from 2022.
  • Sanofi 2022 EBITDA was 14.324B, a 3.72% increase from 2021.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.

Sanofi EBITDA 2010-2025 | SNY

  • Sanofi 2024 EBITDA was 12.1B, a 18.13% decline from 2023.
  • Sanofi 2023 EBITDA was 14.78B, a 3.18% increase from 2022.
  • Sanofi 2022 EBITDA was 14.324B, a 3.72% increase from 2021.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$796.4B
Johnson & Johnson (JNJ)$379.5B
AbbVie (ABBV)$306B
Novo Nordisk (NVO)$260.6B
Roche Holding AG (RHHBY)$248.1B
Novartis AG (NVS)$234.2B
Merck (MRK)$196.7B
Pfizer (PFE)$125.6B
Bayer (BAYRY)$23.7B
Innoviva (INVA)$1.1B